Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)

NCT04596839 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: Remdesivir
OTHER: Standard of Care

Sponsor

Dr. Md. Alimur Reza